Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 845.00
-9.60 (-1.12%)
Jul 13, 2026, 3:30 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 68.78 billion as of July 13, 2026. Its market cap has increased by 25.34% in one year.
Market Cap
68.78B
Enterprise Value
68.05B
Revenue
8.28B
Ranking
n/a
PE Ratio
32.89
Stock Price
845.00
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 68.78B, an increase of 118.65%. That is a compound annual growth rate of 18.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 68.78B | 13.72% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 677.29B |
| Anthem Biosciences | 425.04B |
| OneSource Specialty Pharma | 186.52B |
| Concord Biotech | 136.49B |
| Blue Jet Healthcare | 108.25B |
| Zota Health Care | 49.28B |
| Panacea Biotec | 33.48B |
| Dishman Carbogen Amcis | 30.71B |